FDA invited participation in pilot projects intended to assist the agency and members of the pharmaceutical distribution chain in the development of an electronic system that will identify and trace certain prescription drugs, as outlined within the Drug Supply Chain Security Act (DSCSA). Participation is voluntary, and FDA will ensure that participation reflects the diversity of the supply chain, including large and small entities from all industry sectors.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
